Skip to content

COVID-19 treatment outcomes at the University Medical Center Freiburg

COVID-19 treatment outcomes at the University Medical Center Freiburg

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00021775
Enrollment
400
Registered
2020-06-10
Start date
2020-05-31
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1

Interventions

Group 1: Epidemiological, clinical and management data as well as treatment outcomes of COVID-19 patients that are treated at the University Medical Center Freiburg are retrospectively collected and a

Sponsors

Abteilung Infektiologie, Klinik für Innere Medizin II, Universitätsklinikum Freiburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Hospitalized patients with COVID-19 (defined by SARS-CoV-2-positve PCR in respiratory sample, stool or blood)

Exclusion criteria

Exclusion criteria: /

Design outcomes

Primary

MeasureTime frame
In-hospital mortality

Secondary

MeasureTime frame
Rates of complications and modes of death, length of hospital stay, ventilation and ECMO support

Countries

Germany

Contacts

Public ContactSiegbert Rieg

Abteilung Infektiologie, Klinik für Innere Medizin II, Universitätsklinikum Freiburg

siegbert.rieg@uniklinik-freiburg.de076127018240

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026